Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Thoratec-HeartWare LVAD Deal Is Dead Following FTC Challenge

This article was originally published in The Gray Sheet

Executive Summary

Thoratec abandoned its planned $282 million acquisition of ventricular-assist-device-maker HeartWare July 31 after the deal was challenged by the Federal Trade Commission
Advertisement

Related Content

Heart Failure Devices: Raising Roadblocks To Readmission
Heart Failure Devices: Raising Roadblocks To Readmission
HeartMate Meets Its Match? HeartWare VAD Data Has Good Showing At AHA
HeartMate Meets Its Match? HeartWare VAD Data Has Good Showing At AHA
Thoratec's HeartMate II Implant Boosts Stroke-Free Survival Four-Fold - Study
Thoratec's HeartMate II Implant Boosts Stroke-Free Survival Four-Fold - Study
Financings In Brief
Financings In Brief

Topics

Advertisement
UsernamePublicRestriction

Register

MT027752

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel